Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
A Randomized, Double-blind, Multicenter, Parallel Designed Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) in Patients With Chronic Low Back Pain
Tutkimuksen yleiskatsaus
Tila
Tila
Ehdot
Ehdot
Interventio / Hoito
Interventio / Hoito
Yksityiskohtainen kuvaus
Opintotyyppi
Opintotyyppi
Ilmoittautuminen (Odotettu)
Ilmoittautuminen
Vaihe
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
Opiskeluyhteys
- Nimi: Eun Jung Kim, Ph.D.
- Puhelinnumero: 82-31-710-3751
- Sähköposti: hanijjung@naver.com
Opiskelupaikat
-
-
Gyeonggi-do
-
Seongnam, Gyeonggi-do, Korean tasavalta, 463-865
- Rekrytointi
- Donnguk University Oriental Medical Hospital
-
Ottaa yhteyttä:
- Eun Jung Kim, Ph.D.
- Puhelinnumero: 82-31-710-3751
- Sähköposti: hanijjung@naver.com
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- At least 20 years of age, but below 75 years of age
- Low back pain in the last 3 months or more
- Low back pain rated over 40 mm on a 100 mm Visual Analog Scale (VAS)
- Those who are reliable and willing to cooperate in this test, and obey the restrictions for the treatment period.
- An understanding of the objectives, methods and efficacy of the clinical trial, and willingness in completing the consent form.
Exclusion Criteria:
- Trauma to or surgery on the lumbar region within 6 months prior to enrollment
- Low back pain accompanied by sciatica
- Systematic disease, and severe dysfunction due to the medical illness (e.g. cancer, infection, etc.)
- A history of medication, oriental medical treatment, physiotherapy for treating low back pain within the last 4 weeks
- Neurological disease, such as topical or whole body hypoesthesia in temperature sensation (e.g. stroke, peripheral neuropathy, etc.)
- Hypersensitivity in heating and cooling stimulation
- Pregnant and lactating women
- Participate in the other clinical trials within the last 3 months or after enroll this trial
- When researchers evaluate that it is not appropriate to participate in this clinical test
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kolminkertaistaa
Aseiden lukumäärä
Aseet ja interventiot
Osallistujaryhmä / ArmOsallistujaryhmä / Arm |
Interventio / HoitoInterventio / Hoito |
|---|---|
|
Kokeellinen: Heating and cooling combination therapy
The patients in this group received heating and cooling combination therapy by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience.
Doctor press 8 acupuncture points which is treated in LBP patients and select the most painful 2 acupuncture points.
Device's probe is attached to the acupuncture points in 15 minutes.
Probe's temperature is changed 5 cycles from maximum 45℃ to minimum 15℃.
|
The treatment was applied 10 times for 4 weeks.
Most painful 2 points in 8 acupuncture points(both side of Bladder meridian23 (BL23), BL24, BL25, BL26) were used for all the patients assigned to this group.
Muut nimet:
|
|
Huijausvertailija: Sham heating and cooling therapy
The patients in this group received sham heating and cooling combination therapy in same conditions of treatment group except the temperature.
Before the treatment begin, caregiver measure the patient's skin temperature.
Then probe's temperature is changed 5 cycles from 1℃ over the skin temperature to 1℃ under the skin temperature.
|
The treatment was applied 10 times for 4 weeks.
The sham heating and cooling combination therapy was applied on the 2 of 8 same acupuncture points as in the treatment group.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change from baseline in 100mm Pain Visual Analogue Scale (VAS)
Aikaikkuna: at baseline and 4 4 weeks later from baseline
|
The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'
|
at baseline and 4 4 weeks later from baseline
|
Toissijaiset tulostoimenpiteet
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change from baseline in 100mm Pain Visual Analogue Scale (VAS)
Aikaikkuna: estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'
|
estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
|
Change from baseline in Korean Oswestry disability index (KODI)
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
KODI is checked by the patients.
KODI is a questionnaire to measure the back-related disability.
KODI consists of combination of physical and social restriction through 9 questions covering different dimensions of daily living.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Korean Roland Morris Disability Questionnaire (KRMDQ)
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
KRMDQ is checked by the patients.
KRMDQ is a questionnaire to measure the back-related disability.
KRMDQ consists of 24 questions answered yes or no.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Traditional Medicine Back pain Questionnaire (TMBQ)
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
TMBQ is checked by the patients.
TMBQ is a questionnaire to measure the back-related disability in aspect of oriental medicine.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Modified schöber test
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Modified schöber test measures the flexion range of motion of lumbar spine.
First, investigator marks the point at patients' lumbosacral junction.
Then also marks the points at upper 10cm and lower 5cm of the former point in standing position.
After marking the 3 points, patients bend anteriorly as best he or she can.
Then, investigator measures the length of the latter 2 points.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Finger-to-floor distance
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Finger-to-floor distance measures the flexion range of motion of lumbar spine.
Patients stand on the box which height is 20cm.
Then, patients bend anteriorly in extension of knee and upper limb.
Investigator measures the length from floor to 3rd finger.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Finger-to-thigh distraction
Aikaikkuna: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Finger-to-thigh distraction measures the lateral bending range of motion of lumbar spine.
Patients stand on the box which height is 20cm.
Then, patients bend laterally in extension of knee and upper limb.
Investigator measures the length from floor to 3rd finger.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Adverse Events
Aikaikkuna: estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.
|
estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
Yhteistyökumppanit ja tutkijat
Sponsori
Sponsori
Yhteistyökumppanit
Yhteistyökumppanit
Tutkijat
Tutkijat
- Päätutkija: Seung Deok Lee, Ph.D., Donnguk University Oriental Medical center
Julkaisuja ja hyödyllisiä linkkejä
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Opiskelun aloitus
Ensisijainen valmistuminen (Odotettu)
Ensisijainen valmistuminen
Opintojen valmistuminen (Odotettu)
Opintojen valmistuminen
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Ensimmäinen Lähetetty
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Arvio)
Viimeisin päivitys julkaistu
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
Muut tutkimustunnusnumerot
- OCH-S100-2014
- HI11C2135 (Muu apuraha/rahoitusnumero: The Korea Health Industry Development Institute)
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .